James S Y, Mackay A G, Colston K W
Department of Clinical Biochemistry, St. George's Hospital Medical School, London, U.K.
J Steroid Biochem Mol Biol. 1996 Jul;58(4):395-401. doi: 10.1016/0960-0760(96)00048-9.
Vitamin D derivatives have been shown both to inhibit the proliferation of cultured breast cancer cells and to cause regression of experimental mammary tumours in vivo. We have investigated the ability of several vitamin D analogues to promote the regression of experimental rat mammary tumours. Our results revealed that one vitamin D compound in particular, EB1089 (1(S),3(R)-dihydroxy-20(R)-5'-ethyl- 5'-hydroxy-hepta-1'(E),3'(E)-dien-1'-yl)-9,10-secopregna-5(Z ),7(E) ,10(19)-triene), was highly effective at inhibiting tumour progression, without causing a significant rise in serum calcium concentration. Tumour regression occurs when the rate of cell death is greater than the rate of cell proliferation. Apoptosis (programmed or active cell death) is an active, energy-dependent process in which a distinct series of biochemical and molecular events leads to the death of cells by specific signals. We have examined effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2(D)3) and the synthetic vitamin D analogue EB1089 on indices of apoptosis in cultured human breast cancer cells. The effects of the vitamin D compounds on the expression of two oncoproteins which may regulate apoptosis, bcl-2 and p53 were examined by Western analysis. In MCF-7 cell cultures treated for six days with 1,25(OH)2(D)3 or EB1089 (1 x 10(-8) M), bcl-2 protein was reduced in comparison to control levels, whereas p53 protein was increased. In addition, the p21 protein, whose gene WAF-1 is induced by wild type p53, was also increased by both vitamin D compounds. Using Northern analysis, it was observed that 24-h treatment of MCF-7 cells with 1 x 10(-8) M 1,25(OH)2(D)3 or EB1089 resulted in an induction of TRPM-2 (clusterin) mRNA, a gene associated with onset of apoptosis in the involuting prostate. Fragmentation of genomic DNA is a characteristic feature of apoptosis. With the terminal deoxynucleotidyl transferase (TdT) assay, 3'-OH DNA breaks indicative of DNA fragmentation were detected histochemically in MCF-7 cells treated with 1 x 10(-8) M 1,25(OH)2(D)3 or EB1089 for four days prior to fixation and TdT reaction. Further evidence of apoptosis was obtained following six days treatment of MCF-7 cell cultures with 5 x 10(-8) M 1,25(OH)2(D)3 or EB1089, utilizing a cell death ELISA assay, which measures the presence of histone-associated oligonucleosome complexes generated from DNA fragmentation. Taken together our findings indicate that vitamin D derivatives may play a role in regulating the expression of genes and protein products implicated in apoptosis.
维生素D衍生物已被证明既能抑制培养的乳腺癌细胞增殖,又能使实验性乳腺肿瘤在体内消退。我们研究了几种维生素D类似物促进实验性大鼠乳腺肿瘤消退的能力。我们的结果显示,一种特别的维生素D化合物,即EB1089(1(S),3(R)-二羟基-20(R)-5'-乙基-5'-羟基-庚-1'(E),3'(E)-二烯-1'-基)-9,10-孕甾二烯-5(Z),7(E),10(19)-三烯),在抑制肿瘤进展方面非常有效,且不会导致血清钙浓度显著升高。当细胞死亡速率大于细胞增殖速率时,肿瘤会发生消退。凋亡(程序性或主动细胞死亡)是一个活跃的、能量依赖的过程,在这个过程中,一系列独特的生化和分子事件通过特定信号导致细胞死亡。我们研究了1,25-二羟基维生素D3(1,25(OH)2(D)3)和合成维生素D类似物EB1089对培养的人乳腺癌细胞凋亡指标的影响。通过蛋白质免疫印迹分析检测了维生素D化合物对两种可能调节凋亡的癌蛋白bcl-2和p53表达的影响。在用1,25(OH)2(D)3或EB1089(1×10(-8)M)处理6天的MCF-7细胞培养物中,与对照水平相比,bcl-2蛋白减少,而p53蛋白增加。此外,其基因WAF-1由野生型p53诱导的p21蛋白,也被两种维生素D化合物增加。通过Northern印迹分析观察到,用1×10(-8)M 1,25(OH)2(D)3或EB1089处理MCF-7细胞24小时会诱导TRPM-2(聚集素)mRNA,这是一个与前列腺退化过程中凋亡开始相关的基因。基因组DNA片段化是凋亡的一个特征。通过末端脱氧核苷酸转移酶(TdT)检测,在用1×10(-8)M 1,25(OH)2(D)3或EB1089处理4天,然后固定并进行TdT反应之前的MCF-7细胞中,通过组织化学检测到了指示DNA片段化的3'-OH DNA断裂。在用5×10(-8)M 1,25(OH)2(D)3或EB1089处理MCF-7细胞培养物6天后,利用细胞死亡ELISA检测获得了凋亡的进一步证据,该检测可测量由DNA片段化产生的组蛋白相关寡核小体复合物的存在。综上所述,我们的研究结果表明维生素D衍生物可能在调节与凋亡相关的基因和蛋白质产物的表达中发挥作用。